Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer
Honghu Zhang, Lin Qi, Yi Cai, Xiaomei Gao
Abstract
In conclusion, this review highlights the emerging role of GRPR in prostate cancer diagnosis and treatment. Moreover, the integration of radionuclide-targeted therapy with GRPR antagonists introduces an innovative therapeutic approach that holds promise for improving outcomes in individuals dealing with prostate cancer. The potential prognostic value of GRPR in assessing the disease's progression adds another dimension to its clinical significance in the realm of urology.
Topics & Concepts
Prostate cancerMedicineOncologyCancerBiomarkerProstateDiseaseTargeted therapyInternal medicineBiologyBiochemistryProstate Cancer Treatment and ResearchNeuropeptides and Animal PhysiologyPeptidase Inhibition and Analysis